AQR Capital Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$468K Buy
+29,444
New +$639K ﹤0.01% 3156
2023
Q2
Sell
-112,949
Closed -$3.53M 2217
2023
Q1
$3.53M Sell
112,949
-48,502
-30% -$1.56M 0.01% 1040
2022
Q4
$4.81M Buy
161,451
+65,682
+69% +$2.35M 0.01% 910
2022
Q3
$3.65M Buy
95,769
+56,562
+144% +$2.84M 0.01% 951
2022
Q2
$2.14M Buy
39,207
+4,824
+14% +$265K ﹤0.01% 1071
2022
Q1
$2.15M Buy
34,383
+19,385
+129% +$1.28M ﹤0.01% 1137
2021
Q4
$1.51M Buy
14,998
+2,916
+24% +$256K ﹤0.01% 1344
2021
Q3
$1.09M Sell
12,082
-1,241
-9% -$113K ﹤0.01% 1490
2021
Q2
$1.23M Buy
13,323
+6,444
+94% +$515K ﹤0.01% 1490
2021
Q1
$665K Sell
6,879
-3,222
-32% -$333K ﹤0.01% 1727
2020
Q4
$526K Sell
10,101
-3,894
-28% -$163K ﹤0.01% 1757
2020
Q3
$560K Buy
+13,995
New +$438K ﹤0.01% 1672

Other funds holding FLGT